Pain related to intravitreal injections for age-related macular degeneration: a qualitative study of the perspectives of patients and practitioners
Objectives Ocular pain is a commonly reported finding in the intravitreal injection procedure, but post-injection experiences and patient adherence to treatment remain underexplored. We therefore aimed to identify key variations in the intravitreal injection procedure that may influence pain, and to...
Main Authors: | Heather Waterman, Sanjiv Banerjee, Christina Yiallouridou, Jennifer H Acton, Ashley Wood |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-08-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/13/8/e069625.full |
Similar Items
-
Efficiency of Intravitreal Ranibizumab Injection in Wet Age-Related Macular Degeneration
by: Didem sahin, et al.
Published: (2015-12-01) -
Comment on “Intravitreal conbercept injection for neovascular age-related macular degeneration”
by: Dan Călugăru, et al.
Published: (2020-02-01) -
Intravitreal injection of Conbercept in the treatment of exudative age-related macular degeneration
by: Hong-Xia Niu, et al.
Published: (2018-09-01) -
Effect of intravitreal injection of conbercept on neovascular age-related macular degeneration
by: Tao Li, et al.
Published: (2019-04-01) -
Use of intravitreal injection of triamcinolone acetonide in the treatment of age-related macular degeneration
by: Gopal Lekha, et al.
Published: (2007-01-01)